查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462787

過敏免疫治療市場至2030年的預測：按類型、過敏類型、分銷管道、最終用戶和地區的全球分析

Allergy Immunotherapy Market Forecasts to 2030 - Global Analysis By Type, Allergy Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2023年全球過敏免疫療法市場規模為 26.7 億美元，預計預測期內年複合成長率為 11.6%，到 ​​2030年將達到 57.7 億美元。

過敏免疫療法，也稱為過敏注射或減敏療法，是治療方法治療花粉症、氣喘和食物過敏等過敏症的方法。它的工作原理是讓免疫系統暴露在逐漸增加的過敏原中，重新訓練它以免反應過度，引發過敏症狀。與僅控制症狀的藥物療法不同，免疫療法提供了長期解決方案，甚至是潛在的治癒方法，對於那些尋求緩解慢性過敏的人來說是一種有前途的方法，改善患者的生活品質並減少對症狀藥物治療的依賴。

根據美國過敏、氣喘和免疫學院的估計，18 歲以上的美國人口中約有 7.8%患有過敏性鼻炎。

過敏盛行率上升

隨著越來越多的人出現氣喘、花粉症和食物過敏等過敏症，人們對長期解決方案的需求不斷成長，而不僅僅是簡單地控制症狀。過敏免疫療法提供了一種獨特的方法，可以透過逐漸使免疫系統對過敏原脫敏來治癒過敏。對永久性解決方案不斷成長的需求，加上過敏症患者數量的不斷成長，為開發和提供免疫療法的公司創造重要的市場機會。

治療費用

提取過敏原、諮詢醫生和監測副作用的成本可能很高。這種經濟負擔可能會限制免疫療法的獲得，特別是對於沒有足夠經濟能力的患者。此外，對長期治療和持續後續觀察的需求增加了整體成本負擔，並為尋求這種有益治療方法的患者造成了障礙。

個人化醫療日益受到關注

對個人化醫療的日益關注是過敏免疫治療市場的重大機會。透過根據每位患者的過敏傾向制定治療計劃（考慮觸發因素、年齡和病史等因素），個人化免疫療法有望提高療效和安全性。這種有針對性的方法可以使免疫療法對許多因擔心療效或副作用而猶豫不決的患者更具吸引力，並最終可能導致市場的顯著擴張。

替代治療方案

抗組織胺和皮質類固醇等藥物與免疫療法以及解決方法存在競爭。這些替代療法因其方便和安全而可能受到患者和醫療保健提供者的青睞。這可能會威脅免疫療法的市場滲透率和採用率，影響醫療保健提供者的收益來源並限制整體市場成長潛力。

COVID-19 的影響

最初，對潛在相互作用的擔憂和有限的醫療機會導致了混亂，包括延遲開始治療以及轉向舌下免疫療法（舌下給藥）以盡量減少接觸。然而，這場大流行凸顯了管理過敏等慢性疾病的重要性，也可能導致未來對免疫療法等長期解決方案的需求增加。

預計食物過敏領域在預測期內將是最大的

預計食物過敏領域將佔最大佔有率。食物過敏的免疫療法包括逐漸將身體暴露於過敏原食物中，以使免疫系統脫敏並降低過敏反應的嚴重程度。這種有針對性的方法提供了治癒食物過敏的潛力，而不僅僅是症狀管理，使其成為許多患者的有吸引力的選擇。隨著食物過敏變得更加普遍，這一領域預計將顯著成長。

預計零售藥局領域在預測期內年複合成長率最高

預計零售藥局業務在預測期內將出現良好成長。的零售藥局備有免疫療法所需的各種過敏原萃取物、藥物和用品。零售藥局的藥劑師為接受免疫治療的患者提供諮詢、教育和支持，以確保正確的劑量、監測副作用並最佳化治療依從性。由於其存在和可及性，零售藥局在擴大患者獲得過敏免疫治療的機會以及改善患者治療效果和滿意度方面發揮關鍵作用。

佔比最高的地區

由於過敏流行率上升、可支配收入增加、大型製藥企業在新興市場的存在等，亞太地區在預測期內獲得了最大的市場佔有率。這些公司投資舌下免疫療法和改進過敏原標準化等先進技術，使治療更容易獲得和更有效。再加上人們對過敏管理的認知不斷提高，亞太地區成為過敏免疫療法市場的關鍵成長引擎。

年複合成長率最高的地區：

由於過敏症發病率高、社會對免疫療法作為治療選擇的認知較高，以及預計有利於獲得的強大的醫療基礎設施，北美地區有望在預測期內實現盈利成長。此外，北美是過敏免疫療法研發的溫床，不斷推出創新治療方法。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球過敏免疫治療市場：依類型

  • 舌下免疫治療
  • 皮下免疫治療
  • 特異性免疫治療

第6章 全球過敏免疫治療市場：依過敏類型

  • 過敏性氣喘
  • 過敏性鼻炎
  • 異位性皮膚炎
  • 食物過敏
  • 其他過敏類型

第7章 全球過敏免疫治療市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第8章 全球過敏免疫治療市場：依最終用戶分類

  • 醫院
  • 診所
  • 診斷中心

第9章 全球過敏免疫治療市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • ALK Abello
  • Allergy Therapeutics
  • Stallergenes Greer
  • Mylan NV
  • Arrayit Corporation
  • Merck KGaA
  • Biomay AG
  • HollisterStier Allergy
  • HAL Allergy Group
  • ASIT Biotech
  • LETIPharma
  • Dermapharm Holding SE
  • Carcassia
  • Anergis
  • DVB Technologies SA
  • Adamis Pharmaceuticals Corporation
Product Code: SMRC25839

According to Stratistics MRC, the Global Allergy Immunotherapy Market is accounted for $2.67 billion in 2023 and is expected to reach $5.77 billion by 2030 growing at a CAGR of 11.6% during the forecast period. Allergy immunotherapy, also known as allergy shots or desensitization, is a treatment for allergies like pollen allergies, asthma, and food allergies. It works by gradually exposing the immune system to increasing amounts of allergens, retraining it to not overreact, and causing allergy symptoms. Unlike medications that just manage symptoms, immunotherapy offers the potential for a long-term solution or even a cure, making it a promising approach for those seeking relief from chronic allergies, thereby improving patient quality of life and reducing reliance on symptomatic medications.

According to the estimates of the American Academy of Allergy Asthma & Immunology, nearly 7.8% of the American population aged above 18 develops allergic rhinitis.

Market Dynamics:

Driver:

Rising prevalence of allergies

As more people develop allergies like asthma, hay fever, and food sensitivities, the demand for long-term solutions beyond just managing symptoms grows. Allergy immunotherapy offers a unique approach by gradually desensitizing the immune system to allergens, potentially curing allergies altogether. This increased need for a permanent solution, coupled with a growing population of allergy sufferers, creates a significant market opportunity for companies developing and delivering immunotherapy treatments.

Restraint:

Cost of treatment

Expenses associated with allergen extracts, physician visits, and monitoring for adverse reactions can be substantial. This financial burden may limit access to immunotherapy for some patients, particularly those without adequate financial resources. Also, the long-term nature of treatment and the need for continued follow-up appointments contribute to the overall cost, making it a barrier for individuals seeking this potentially beneficial therapy.

Opportunity:

Increasing focus on personalized medicine

The growing focus on personalized medicine unlocks a key opportunity for the Allergy Immunotherapy Market. By tailoring treatment plans to individual patients' specific allergies (considering factors like triggers, age, and medical history), personalized immunotherapy offers the potential for increased efficacy and improved safety. This targeted approach could make immunotherapy more attractive to a wider patient pool that might have been hesitant due to concerns about effectiveness or side effects, ultimately leading to significant market expansion.

Threat:

Alternative treatment options

Pharmacotherapy like antihistamines and corticosteroids, along with avoidance measures, compete with immunotherapy. These alternatives may be preferred by patients and healthcare providers due to convenience and perceived safety. This threatens market penetration and adoption rates of immunotherapy, potentially impacting revenue streams for providers and limiting the market's overall growth potential.

Covid-19 Impact

Initially, concerns about potential interactions and limited healthcare access caused disruptions, like delays in treatment initiation and a shift towards favoured sublingual immunotherapy methods (administered under the tongue) to minimize contact. However, the pandemic also highlighted the importance of managing chronic conditions like allergies, potentially leading to a future increase in demand for long-term solutions like immunotherapy.

The food allergy segment is expected to be the largest during the forecast period

The food allergy segment is estimated to hold the largest share. Immunotherapy for food allergies involves gradually exposing the body to increasing amounts of the allergenic food, with the goal of desensitizing the immune system and reducing the severity of allergic reactions. This targeted approach offers a potential cure for food allergies, as opposed to just managing symptoms, making it an attractive option for many patients. As food allergies become more prevalent, the segment is expected to see significant growth.

The retail pharmacy segment is expected to have the highest CAGR during the forecast period

The retail pharmacy segment is anticipated to have lucrative growth during the forecast period. Retail pharmacies stock a variety of allergen extracts, medications, and supplies necessary for immunotherapy treatments. Pharmacists at retail pharmacies provide counselling, education, and support to patients undergoing immunotherapy, ensuring proper administration, monitoring for adverse reactions, and optimizing treatment adherence. With their widespread presence and accessibility, retail pharmacies play a crucial role in expanding patient access to allergy immunotherapy and improving overall patient outcomes and satisfaction.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to growing prevalence of allergies, increasing disposable income, and a strong presence of major pharmaceutical companies in developing Asian markets. These companies are investing in advancements like sublingual immunotherapy and improved allergen standardization, making the treatment more accessible and efficient. This, coupled with rising awareness about allergy management, positions the Asia Pacific region as a major growth engine for the Allergy Immunotherapy Market.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to high prevalence of allergies, strong public awareness about immunotherapy as a treatment option, and a robust healthcare infrastructure that facilitates access. Moreover, North America serves as a hotbed for research and development in allergy immunotherapy, constantly innovating and introducing novel treatment methods.

Key players in the market

Some of the key players in the Allergy Immunotherapy Market include ALK Abello, Allergy Therapeutics, Stallergenes Greer, Mylan N.V., Arrayit Corporation, Merck KGaA, Biomay AG, HollisterStier Allergy, HAL Allergy Group, ASIT Biotech, LETIPharma, Dermapharm Holding SE, Carcassia, Anergis, DVB Technologies SA, Adamis Pharmaceuticals Corporation.

Key Developments:

In July 2022, Stallergenes Greer, a global healthcare company that specializes in allergen immunotherapy (AIT), announced the positive data related to the significant benefit of sublingual liquid allergen immunotherapy treatment (AIT) on the onset and worsening of asthma in patients with allergic rhinitis

In April 2021, ALK initiated a clinical trial to study the safety and efficacy of sublingual immunotherapy tablets in children and adolescents suffering from allergic rhinitis induced by birch pollen.

Types Covered:

  • Sublingual Immunotherapy
  • Subcutaneous Immunotherapy
  • Specific Immunotherapy

Allergy Types Covered:

  • Allergic Asthma
  • Allergic Rhinitis
  • Atopic Dermatitis
  • Food Allergy
  • Other Allergy Types

Distribution Channels Covered:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

End Users Covered:

  • Hospitals
  • Clinics
  • Diagnostic Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Allergy Immunotherapy Market, By Type

  • 5.1 Introduction
  • 5.2 Sublingual Immunotherapy
  • 5.3 Subcutaneous Immunotherapy
  • 5.4 Specific Immunotherapy

6 Global Allergy Immunotherapy Market, By Allergy Type

  • 6.1 Introduction
  • 6.2 Allergic Asthma
  • 6.3 Allergic Rhinitis
  • 6.4 Atopic Dermatitis
  • 6.5 Food Allergy
  • 6.6 Other Allergy Types

7 Global Allergy Immunotherapy Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacy
  • 7.3 Online Pharmacy
  • 7.4 Retail Pharmacy

8 Global Allergy Immunotherapy Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Diagnostic Centers

9 Global Allergy Immunotherapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 ALK Abello
  • 11.2 Allergy Therapeutics
  • 11.3 Stallergenes Greer
  • 11.4 Mylan N.V.
  • 11.5 Arrayit Corporation
  • 11.6 Merck KGaA
  • 11.7 Biomay AG
  • 11.8 HollisterStier Allergy
  • 11.9 HAL Allergy Group
  • 11.10 ASIT Biotech
  • 11.11 LETIPharma
  • 11.12 Dermapharm Holding SE
  • 11.13 Carcassia
  • 11.14 Anergis
  • 11.15 DVB Technologies SA
  • 11.16 Adamis Pharmaceuticals Corporation

List of Tables

  • Table 1 Global Allergy Immunotherapy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 4 Global Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 5 Global Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 6 Global Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 7 Global Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 8 Global Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 9 Global Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 10 Global Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 11 Global Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 12 Global Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 13 Global Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 14 Global Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 15 Global Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 16 Global Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 18 Global Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 19 Global Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 20 North America Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 21 North America Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 22 North America Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 23 North America Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 24 North America Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 25 North America Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 26 North America Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 27 North America Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 28 North America Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 29 North America Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 30 North America Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 31 North America Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 32 North America Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 33 North America Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 34 North America Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 35 North America Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 North America Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 37 North America Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 38 North America Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 39 Europe Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 40 Europe Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 41 Europe Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 42 Europe Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 43 Europe Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 44 Europe Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 45 Europe Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 46 Europe Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 47 Europe Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 48 Europe Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 49 Europe Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 50 Europe Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 51 Europe Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 52 Europe Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 53 Europe Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 54 Europe Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 55 Europe Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 56 Europe Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 57 Europe Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 58 Asia Pacific Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 59 Asia Pacific Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 60 Asia Pacific Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 61 Asia Pacific Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 62 Asia Pacific Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 63 Asia Pacific Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 64 Asia Pacific Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 65 Asia Pacific Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 66 Asia Pacific Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 67 Asia Pacific Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 68 Asia Pacific Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 69 Asia Pacific Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 70 Asia Pacific Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 71 Asia Pacific Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 72 Asia Pacific Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 73 Asia Pacific Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 74 Asia Pacific Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 75 Asia Pacific Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 76 Asia Pacific Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 77 South America Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 78 South America Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 79 South America Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 80 South America Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 81 South America Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 82 South America Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 83 South America Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 84 South America Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 85 South America Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 86 South America Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 87 South America Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 88 South America Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 89 South America Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 90 South America Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 91 South America Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 92 South America Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 South America Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 94 South America Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 95 South America Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 96 Middle East & Africa Allergy Immunotherapy Market Outlook, By Country (2021-2030) ($MN)
  • Table 97 Middle East & Africa Allergy Immunotherapy Market Outlook, By Type (2021-2030) ($MN)
  • Table 98 Middle East & Africa Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (2021-2030) ($MN)
  • Table 99 Middle East & Africa Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (2021-2030) ($MN)
  • Table 100 Middle East & Africa Allergy Immunotherapy Market Outlook, By Specific Immunotherapy (2021-2030) ($MN)
  • Table 101 Middle East & Africa Allergy Immunotherapy Market Outlook, By Allergy Type (2021-2030) ($MN)
  • Table 102 Middle East & Africa Allergy Immunotherapy Market Outlook, By Allergic Asthma (2021-2030) ($MN)
  • Table 103 Middle East & Africa Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2021-2030) ($MN)
  • Table 104 Middle East & Africa Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2021-2030) ($MN)
  • Table 105 Middle East & Africa Allergy Immunotherapy Market Outlook, By Food Allergy (2021-2030) ($MN)
  • Table 106 Middle East & Africa Allergy Immunotherapy Market Outlook, By Other Allergy Types (2021-2030) ($MN)
  • Table 107 Middle East & Africa Allergy Immunotherapy Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 108 Middle East & Africa Allergy Immunotherapy Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 109 Middle East & Africa Allergy Immunotherapy Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 110 Middle East & Africa Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 111 Middle East & Africa Allergy Immunotherapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 112 Middle East & Africa Allergy Immunotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 113 Middle East & Africa Allergy Immunotherapy Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 114 Middle East & Africa Allergy Immunotherapy Market Outlook, By Diagnostic Centers (2021-2030) ($MN)